Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice

Adenoviral (Ad) vectors represent promising vaccine platforms for infectious disease. To overcome pre-existing immunity to commonly used human adenovirus serotype 5 (Ad5), vectors based on rare species or non-human Ads are being developed. However, these vectors often exhibit reduced potency compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Bliss, Carly M., Parsons, Andrea J., Nachbagauer, Raffael, Hamilton, Jennifer R., Cappuccini, Federica, Ulaszewska, Marta, Webber, Jason P., Clayton, Aled, Hill, Adrian V.S., Coughlan, Lynda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953706/
https://www.ncbi.nlm.nih.gov/pubmed/31934599
http://dx.doi.org/10.1016/j.omtm.2019.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953706/
https://www.ncbi.nlm.nih.gov/pubmed/31934599
http://dx.doi.org/10.1016/j.omtm.2019.12.003

Ejemplares similares